kr9.49
2.47%
Stockholm, Sep 21, 05:30 pm CEST. Closed.
ISIN
SE0009947534
Symbol
SEDANA

Sedana Medical Target price 2026 - Analyst rating & recommendation

Sedana Medical Classifications & Recommendation

Buy
80%
Hold
20%

Sedana Medical Price Target

Target Price kr24.48
Price kr9.49
Potential
Number of Estimates 3
3 Analysts have issued a price target Sedana Medical 2027 . The average Sedana Medical target price is kr24.48. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 4 Analysts recommend Sedana Medical to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sedana Medical stock has an average upside potential 2027 of . Most analysts recommend the Sedana Medical stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million kr 200.23 213.11
12.02% 6.43%
EBITDA Margin -8.34% -0.95%
58.12% 88.61%
Net Margin -29.59% -13.65%
395.64% 53.86%

2 Analysts have issued a sales forecast Sedana Medical 2026 . The average Sedana Medical sales estimate is

kr213m
unlock
. This is
9.03% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
kr222m 13.35%
unlock
, the lowest is
kr207m 5.79%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 kr200m 12.02%
2026
kr213m 6.43%
unlock
2027
kr280m 31.28%
unlock
2028
kr362m 29.24%
unlock

2 Analysts have issued an Sedana Medical EBITDA forecast 2026. The average Sedana Medical EBITDA estimate is

kr-2.0m
unlock
. This is
63.93% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
kr-2.1m 62.50%
unlock
, the lowest is
kr-2.0m 65.00%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 kr-16.7m 53.09%
2026
kr-2.0m 87.90%
unlock
2027
kr31.3m 1,650.00%
unlock
2028
kr69.7m 122.58%
unlock

EBITDA Margin

2025 -8.34% 58.12%
2026
-0.95% 88.61%
unlock
2027
11.19% 1,277.89%
unlock
2028
19.27% 72.21%
unlock

2 Sedana Medical Analysts have issued a net profit forecast 2026. The average Sedana Medical net profit estimate is

kr-29.1m
unlock
. This is
18.78% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
kr-28.2m 21.21%
unlock
, the lowest is
kr-30.3m 15.57%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 kr-59.2m 455.20%
2026
kr-29.1m 50.88%
unlock
2027
kr2.0m 106.91%
unlock
2028
kr31.1m 1,447.26%
unlock

Net Margin

2025 -29.59% 395.64%
2026
-13.65% 53.86%
unlock
2027
0.72% 105.27%
unlock
2028
8.60% 1,094.44%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share kr -0.60 -0.29
445.45% 51.67%
P/E negative
EV/Sales 4.70

2 Analysts have issued a Sedana Medical forecast for earnings per share. The average Sedana Medical EPS is

kr-0.29
unlock
. This is
19.44% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
kr-0.30 16.67%
unlock
, the lowest is
kr-0.28 22.22%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 kr-0.60 445.45%
2026
kr-0.29 51.67%
unlock
2027
kr0.02 106.90%
unlock
2028
kr0.31 1,450.00%
unlock

P/E ratio

Current -27.03 7.02%
2026
-33.22 22.91%
unlock
2027
481.68 1,549.97%
unlock
2028
31.08 93.55%
unlock

Based on analysts' sales estimates for 2026, the Sedana Medical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.13 13.93%
2026
4.70 8.30%
unlock
2027
3.58 23.83%
unlock
2028
2.77 22.62%
unlock

P/S ratio

Current 5.36 18.89%
2026
4.91 8.28%
unlock
2027
3.74 23.83%
unlock
2028
2.90 22.62%
unlock

Current Sedana Medical Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
PARETO SECURITIES AS
Locked
Locked
Locked Jul 05 2026
PARETO SECURITIES AS
Locked
Locked
Locked Jan 15 2026
PARETO SECURITIES AS
Locked
Locked
Locked Oct 27 2025
PARETO SECURITIES AS
Locked
Locked
Locked Jul 21 2025
PARETO SECURITIES AS
Locked
Locked
Locked Jul 09 2025
PARETO SECURITIES AS
Locked
Locked
Locked Jul 08 2025
PARETO SECURITIES AS
Locked
Locked
Locked Mar 21 2025
Analyst Rating Date
Locked
PARETO SECURITIES AS:
Locked
Locked
Jul 05 2026
Locked
PARETO SECURITIES AS:
Locked
Locked
Jan 15 2026
Locked
PARETO SECURITIES AS:
Locked
Locked
Oct 27 2025
Locked
PARETO SECURITIES AS:
Locked
Locked
Jul 21 2025
Locked
PARETO SECURITIES AS:
Locked
Locked
Jul 09 2025
Locked
PARETO SECURITIES AS:
Locked
Locked
Jul 08 2025
Locked
PARETO SECURITIES AS:
Locked
Locked
Mar 21 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today